Characterization of the SARS-CoV-2 Spike in an Early Prefusion Conformation
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Pandemic coronavirus disease 2019 (COVID-19) is caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for which there are no efficacious vaccines or therapeutics that are urgently needed. We expressed three versions of spike (S) proteins—receptor binding domain (RBD), S1 subunit and S ectodomain—in insect cells. RBD appears monomer in solutions, whereas S1 and S associate into homotrimer with substantial glycosylation. The three proteins confer excellent antigenicity with six convalescent COVID-19 patient sera. Cryo-electron microscopy (cryo-EM) analyses indicate that the SARS-CoV-2 S trimer dominate in a unique conformation distinguished from the classic prefusion conformation of coronaviruses by the upper S1 region at lower position ~15 Å proximal to viral membrane. Such conformation is proposed as an early prefusion state for the SARS-CoV-2 spike that may broaden the knowledge of coronavirus and facilitate vaccine development.
Article activity feed
-
SciScore for 10.1101/2020.03.16.994152: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Unbound antibody was removed by five 5-min washes and the membrane was incubated with alkaline phosphatase-conjugated goat anti-mouse secondary antibody or goat anti-human IgG secondary antibody (Abcam, Cambridge, UK). anti-mousesuggested: Noneanti-human IgGsuggested: NoneHorseradish peroxidase (HRP)-labeled mouse anti-human antibody (Abcam) was used as secondary antibody at 1:5,000 for 30 min. mouse anti-human antibody ( Abcam )suggested: Noneanti-human antibodysuggested: NoneSoftware and Algorithms Sentences Resources In all three constructs, the natural signal peptide (aa 1-14 analyzed by SignalP tool) … SciScore for 10.1101/2020.03.16.994152: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Unbound antibody was removed by five 5-min washes and the membrane was incubated with alkaline phosphatase-conjugated goat anti-mouse secondary antibody or goat anti-human IgG secondary antibody (Abcam, Cambridge, UK). anti-mousesuggested: Noneanti-human IgGsuggested: NoneHorseradish peroxidase (HRP)-labeled mouse anti-human antibody (Abcam) was used as secondary antibody at 1:5,000 for 30 min. mouse anti-human antibody ( Abcam )suggested: Noneanti-human antibodysuggested: NoneSoftware and Algorithms Sentences Resources In all three constructs, the natural signal peptide (aa 1-14 analyzed by SignalP tool) was replaced with a gp67 secretion signal peptide at N-terminus. SignalPsuggested: (SignalP, RRID:SCR_015644)The Half effective titers (ET50) was calculated by sigmoid trend fitting using GraphPad Prism software. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Particles were picked by the ‘Templete picker’ session of cryoSPARC v237. cryoSPARCsuggested: (cryoSPARC, RRID:SCR_016501)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-